Property | Value |
?:abstract
|
-
Deactivation of primed SARS-CoV-2 prior to cell entry constitutes an emergency brake in COVID-19 infection if vaccine-induced antibodies fail to block recognition of the human angiotensin-converting enzyme 2 (hACE2) receptor The timing and locus for the therapeutic intervention are dictated by the cell entry mechanism and by the selective advantage of the dominant D614G mutation
|
is
?:annotates
of
|
|
?:creator
|
|
?:journal
|
-
ACS_Pharmacology_&_Translational_Science
|
?:license
|
|
?:publication_isRelatedTo_Disease
|
|
?:source
|
|
?:title
|
-
Defusing SARS-CoV-2: Emergency Brakes in a Vaccine Failure Scenario
|
?:type
|
|
?:who_covidence_id
|
|
?:year
|
|